Accessibility Menu
Pfizer logo

Pfizer

(NYSE) PFE

Current Price$24.30
Market Cap$139.52BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1968)+33,070%
5 Year-21%
1 Year+2%
1 Month-7%

Pfizer Financials at a Glance

Market Cap

$139.52BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$63.32B

Net Income (TTM)

$7.49B

EPS (TTM)

$1.30

P/E Ratio

18.77

Dividend

$1.72

Beta (Volatility)

0.41 (Low)

Price

$24.30

Volume

189,435

Open

$24.38

Previous Close

$24.48

Daily Range

$24.19 - $24.42

52-Week Range

$23.11 - $28.75

Estimated Earnings Date

Aug 4, 2026

About Pfizer

Industry

Pharmaceuticals

Employees

75,000

CEO

Albert Bourla, PhD, DVM

Headquarters

New York City, NY 10001-2192, US

PFE Financials

Key Financial Metrics (TTM)

Gross Margin

69.35%

Operating Margin

23.45%

Net Income Margin

11.83%

Return on Equity

8.37%

Return on Capital

10.03%

Return on Assets

3.61%

Earnings Yield

5.33%

Dividend Yield

7.03%

Payout Ratio

1.31%

Stock Overview

Market Cap

$139.52BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

5.70B

Volume

189.44K

Avg. Volume

40.23M

Financials (TTM)

Gross Profit

$43.91B

Operating Income

$14.85B

EBITDA

$16.75B

Operating Cash Flow

$11.99B

Capital Expenditure

-$2.50B

Free Cash Flow

$9.48B

Cash & ST Invst.

$13.08B

Total Debt

$64.46B

Pfizer Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$14.45B

+5.4%

Gross Profit

$9.72B

-1.1%

Gross Margin

67.26%

N/A

Market Cap

$139.52BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.86M

N/A

Employees

75,000

N/A

Net Income

$2.69B

-9.4%

EBITDA

$5.02B

-0.7%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$13.08B

-24.5%

Total Debt

$64.46B

+5.2%

Accounts Receivable

$12.59B

-14.6%

Inventory

$10.67B

-1.7%

Long Term Debt

$60.57B

+6.6%

Short Term Debt

$3.89B

-13.0%

Return on Assets

3.61%

N/A

Return on Invested Capital

8.57%

N/A

Free Cash Flow

$2.18B

+23.0%

Operating Cash Flow

$2.62B

+12.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
DHRDanaher Corporation
$199.31-0.42%
SYKStryker Corporation
$311.76-5.94%
BMYBristol-Myers Squibb Company
$58.30-1.75%
GILDGilead Sciences, Inc.
$130.77-0.48%

Trending Stocks

Symbol / CompanyPricePrice Chg
CLSKCleanSpark
$13.41+0.08%
SKHYSK Hynix
$170.75+0.12%
SOFISoFi Technologies
$18.75+0.03%
FIGFigma
$22.55-0.05%

Questions About PFE

What is the current price of Pfizer?

Pfizer is trading at $24.30 per share.

What is the 52-week range for Pfizer?

Over the past 52 weeks, Pfizer has traded between $23.11 and $28.75.

How much debt does Pfizer have?

As of the most recent reporting period, Pfizer reported total debt of $64.46B.

How much cash does Pfizer have on hand?

Pfizer reported $1.70B in cash and cash equivalents in its most recent financial results.

What is Pfizer’s dividend yield?

Pfizer currently has a dividend yield of 7.03%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.